Fenofibrate capsule is a kind of lipid-lowering drug, which is mostly used in clinic for the treatment of hyperlipidemia and the prevention of cardiovascular and cerebrovascular diseases. Fenofibrate capsule has the effect of lowering triglycerides, inhibiting the combined production of LDL and triacylglycerol, while increasing catabolism, lowering density lipoprotein, triacylglycerol and cholesterol. In addition to regulating blood lipids, it can also reduce blood uric acid, make the fibrinogen content lower, and strengthen the effect of anticoagulants. Due to the effect of prompting uric acid discharge, it can reduce the blood uric acid level, and is suitable for patients with hyperlipidemia accompanied by hyperuricemia. Common adverse reactions include polyuria, lupus-like syndrome, acute pancreatitis, thrombocytopenic purpura, hepatic injury, memory impairment and so on. It should be noted that hepatic and renal insufficiency, patients who are allergic to the product and children are prohibited. The use of drugs need to be combined with their own situation under the guidance of a professional doctor, not blindly self-medication.